Associate Professor, Medicine, Geriatrics Division; Feinberg School of Medicine
Cancer Control & Survivorship
View Publications Listing
Dr. McKoy is a clinical cancer/cancer health disparities researcher whose focus is on improving patient safety for older individuals (? 65 years) with cancer. Within the Cancer Center she serves as the Director of Geriatric Oncology. She is engaged in active pharmacovigilance, including the detection and assessment of safety signals related to drugs and devices and the timely dissemination of findings to relevant stakeholders. A related research focus is comparative and cost effectiveness analyses of cancer related therapies targeted at older cancer patients and safe and cost-effective transitions of care for this cohort. Dr. McKoy is engaged in a collaborative NCI sponsored minority biobanking/biospecimen collection initiative with colleagues at several comprehensive cancer centers across the country. Future studies in pharmacogenomics are expected to aid in prescribing decisions and will likely predict older cancer patients who will respond appropriately to a given cancer-related medication or experience severe adverse drug reactions.